Senate Democrats Challenge Nominee's Vaccine Stance Amid Measles Surge
At a Senate Finance Committee hearing, HHS deputy secretary nominee Chris Klomp affirmed the MMR vaccine's effectiveness but stopped short of a definitive statement on its link to autism, drawing criticism from Senator Ron Wyden. Wyden announced he would oppose Klomp's confirmation, citing confusing testimony during a period of rising measles cases. Klomp currently serves as HHS chief counselor and was praised by Republican chairman Mike Crapo as well-qualified for the role.
Klomp, currently HHS chief counselor, testified that the MMR vaccine is 97% effective after two doses and represents the strongest defense against measles. However, his cautious phrasing regarding autism — noting the causes remain unknown — prompted Wyden to characterize the testimony as contradictory and announce his opposition.
The hearing also examined a recent executive order recommending separate vaccines for each MMR component, which Senator Hassan questioned as lacking scientific support. Senator Whitehouse separately raised Medicare wage index disparities affecting Rhode Island and prior authorization concerns within value-based care arrangements.
This confirmation dispute could shape public perception of vaccine safety during a period of rising measles cases. If Klomp's nomination advances despite Wyden's opposition, federal health messaging may remain ambiguous regarding vaccine-autism questions, potentially influencing parental decisions about childhood immunizations. The outcome could also signal how the administration balances public health guidance against political pressures, affecting trust in HHS communications among families and healthcare providers nationwide.